Skip to content
Search

Latest Stories

Patients experience lower mortality rates when treated by female doctors, study reveals

Patients experience lower mortality rates when treated by female doctors, study reveals

Women are more likely to benefit from receiving treatment from female doctors than men

If you believe you'll feel better under the care of a female doctor, you may not be wrong. Researcher have found a correlation between the gender of physicians and clinical outcomes for patients.


Hospital patients have lower mortality and readmission rates when treated by female physicians, according to a study published recently in the journal Annals of Internal Medicine.

Moreover, the benefit of receiving care from female physicians was found to be larger for female patients than for male patients.

Female patients showed a mortality rate of 8.15 per cent when treated by a female doctor, compared to 8.38 per cent under the care of a male physician.

Among men, 10.15 per cent experienced mortality within 30 days of discharge under the care of a female doctor, compared to 10.23 percent with a male physician.

It is a small but “significant” difference, noted the scientists from the University of California, Los Angeles (UCLA) who suggested that the difference could be due to male doctors underestimating the severity of their female patients’ illnesses.

They also proposed that the effect could be due to female doctors communicating with their female patients better, and women finding it more comfortable engaging in detailed and sensitive conversations with doctors of the same gender, potentially resulting in better diagnoses and treatment.

Dr Yusuke Tsugawa, the senior author of the study and an associate professor at the David Geffen School of Medicine at UCLA, noted that their research indicated disparities in medical practice between female and male physicians, with a significant impact on patients' health outcomes.

For the study, the researchers used data of Medicare fee-for-service beneficiaries hospitalized with medical conditions between 2016 and 2019 in the United States.

Of 458,100 female and 319,800 male patients included in the study, approximately 31 percent of them were treated by female physicians.

The study found that female patients had a lower likelihood of being readmitted within 30 days if they were under the care of a female doctor. Specifically, 15.23 percent of women with a female physician were readmitted, compared with 16.71 percent of women with a male physician.

Dr Tsugawa emphasised the importance of conducting additional research into the underlying mechanisms linking physician gender with patient outcomes, as well as understanding why the benefits differed between female and male patients.

This exploration has “the potential to improve patient outcomes across the board,” he said.

Acknowledging that female physicians deliver high-quality care and that increasing their representation benefits patients, the researchers recommended addressing pay disparities within the profession.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less